$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 20 years by 5.9% on an annualized basis producing an average annual return of 15.23%. Currently, Alnylam Pharmaceuticals has a market
Alnylam is a company that made investors more money over 20 years than most other stocks did—growing money faster than the typical market average. When a company does this over a very long time, it shows it may have made smart choices, but past success doesn't guarantee the future will be the same.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.